Pharmacotherapy of Child and Adolescent Psychiatric Disordersby David Rosenberg
This book fulfils an urgent need for an updated text on pediatric psychopharmacology. It takes a unique approach in discussing recent findings within the context of current issues, including economic and political ones. The book covers the emerging question of treating children who do not yet meet diagnostic criteria for psychosis, e.g, schizophrenia or
This book fulfils an urgent need for an updated text on pediatric psychopharmacology. It takes a unique approach in discussing recent findings within the context of current issues, including economic and political ones. The book covers the emerging question of treating children who do not yet meet diagnostic criteria for psychosis, e.g, schizophrenia or bipolar disorder, but who are deemed to be at high risk. This is an active area of debate: such children are being treated in certain centers, while others reject this completely. The book addresses the antidepressant controversy, the placebo response and unique strategies for delineating this, and ways to optimize the differential between active medication and placebo. It reviews the impact of recent American Heart Association guidelines for monitoring children on stimulants and other psychotropics. It adheres closely to DSM-IV diagnostic criteria throughout. The book describes the use of newly approved drugs such as Lexapro for treating adolescent depression and the novel compound Intuniv. It covers the TADS and CAMS studies, which evaluated the use of SSRIs alone and in combination with cognitive behavioral therapy for adolescent depression. Other topics include treatment of bipolar disorders, the increasing popularity of generic equivalents, combination pharmacotherapy and the potential dangers of psychotropic medications.
- Third edition of the first ever book published on pediatric psychopharmacology from renowned editors.
- Incorporates current developments with regard to SSRIs, their indications and their safety issues, including possible associated suicidal behavior.
- Addresses concerns about cardiovascular side effects of the new stimulant medications available, and compares to other FDA-approved medications for ADHD.
- Features many tables, figures and pictorials, making it highly accessible and reader friendly.
Description: This multiauthored, theoretical, and practical review of prescribing for child and adolescent psychiatric disorders comes 10 years after the previous edition.
Purpose: It provides a much-needed update of pediatric psychopharmacology and it also addresses some of the current trends and controversies in this area. The book is definitely needed, as child psychopharmacology is an area that is understudied, and a good reliable reference is very important for practitioners. The authors do a good job of meeting their objectives.
Audience: The book is targeted at anyone who prescribes psychiatric medications for children or adolescents primarily child and adolescent psychiatrists - but it would be particularly useful for trainees, such as fellows and residents. It also would also be useful to pediatricians who are often relied upon to prescribe but undertrained in the specifics, given the shortage of child psychiatrists in the country. The authors are physicians with good experience treating child and adolescent psychiatric cases.
Features: Several chapters on the general theory and principles behind prescribing medications to children open the book. It covers various background concepts, including (interestingly) current topics such as political developments that affect prescribing patterns. The book then systematically reviews each drug class of importance to child psychiatry. It discusses the history, drug mechanisms, prior workup, usage in clinical practice, dosing, and monitoring guidelines thoroughly and clearly. The book always quotes studies, including the most important landmark studies in child psychiatry, and provides good evidence-based support for its statements. The only minor drawback is that given the textbook format, it is not a good quick reference guide for prescribing nor, to be fair, does it claim to be one.
Assessment: This excellent overview of psychopharmacology for children and adolescents makes strong use of studies and evidence to support its information. The newest edition is up to date (and much needed), and addresses relevant real-world issues related to prescribing. It discusses both the theoretical and practical aspects of medication, making it an essential reference for practicing child psychiatrists in an area for which we have very few reliable, useful, and specific resources.
- Publication date:
- Product dimensions:
- 6.80(w) x 9.90(h) x 1.10(d)
What People are saying about this
Meet the Author
David Rosenberg MD, Miriam L. Hamburger Endowed Chair of Child Psychiatry and Professor & Chief of Child Psychiatry and Psychology at Wayne State University and the Children's Hospital of Michigan, Detroit, MI , USA
Samuel Gershon MD, Emeritus Professor of Psychiatry, University of Pittsburgh, PA, USA
and post it to your social network
Most Helpful Customer Reviews
See all customer reviews >